Skip to main content

Fluticasone / Salmeterol News

Generic, Brand-Name Medication Similarly Effective for COPD

MONDAY, Aug. 7, 2023 – For patients with chronic obstructive pulmonary disease (COPD), generic and brand-name fluticasone-salmeterol are similarly effective and safe, according to a study published...

FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma

JERUSALEM and PARSIPPANY, N.J., July 15, 2019 – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Di...

FDA Medwatch Alert: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

ISSUE: FDA's most prominent warning, the Boxed Warning, about asthma-related death has been removed from the drug labels of medicines that contain both an ICS and LABA. A FDA review of four large...

Teva Announces FDA Approval of AirDuo RespiClick (fluticasone propionate and salmeterol) for Maintenance Treatment of Asthma

JERUSALEM--(BUSINESS WIRE) January 30, 2017 --Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that the U.S. Food and Drug Administration (FDA) has approved AirDuo...

FDA Medwatch Alert: Long-Acting Beta-Agonists (LABAs): New Safe Use Requirements

[UPDATED 04-15-2011] To further evaluate the safety of Long-Acting Beta-Agonists (LABAs) when used in combination with inhaled corticosteroids for the treatment of asthma, the FDA is requiring the...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Asthma - Maintenance, Asthma, Chronic Obstructive Pulmonary Disease

Related drug support groups

Advair Diskus, Advair HFA

Fluticasone / Salmeterol patient information at Drugs.com